NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,072 filers reported holding NOVARTIS A G in Q3 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,276,227 | +1.1% | 81,251 | +0.2% | 1.76% | +8.2% |
| Q2 2023 | $8,185,920 | +9.2% | 81,121 | -0.4% | 1.63% | +5.1% |
| Q1 2023 | $7,496,712 | +9.5% | 81,486 | +8.0% | 1.55% | +9.5% |
| Q4 2022 | $6,847,546 | +20.8% | 75,480 | +1.2% | 1.42% | +11.3% |
| Q3 2022 | $5,669,000 | -9.0% | 74,579 | +1.2% | 1.27% | -3.0% |
| Q2 2022 | $6,228,000 | -1.3% | 73,680 | +2.4% | 1.31% | +7.3% |
| Q1 2022 | $6,313,000 | +4.1% | 71,946 | +3.7% | 1.22% | +7.7% |
| Q4 2021 | $6,067,000 | +11.4% | 69,358 | +4.2% | 1.14% | +2.7% |
| Q3 2021 | $5,444,000 | -2.9% | 66,566 | +8.4% | 1.10% | -10.7% |
| Q2 2021 | $5,604,000 | +13.3% | 61,425 | +6.2% | 1.24% | +1.9% |
| Q1 2021 | $4,946,000 | +0.1% | 57,861 | +10.5% | 1.21% | -12.4% |
| Q4 2020 | $4,943,000 | +18.3% | 52,343 | +8.9% | 1.39% | -3.5% |
| Q3 2020 | $4,180,000 | -0.9% | 48,069 | -0.5% | 1.44% | -6.1% |
| Q2 2020 | $4,219,000 | +1672.7% | 48,302 | +1574.8% | 1.53% | +527.5% |
| Q1 2020 | $238,000 | – | 2,884 | – | 0.24% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EXENCIAL WEALTH ADVISORS, LLC | 188,514 | $13,713,000 | 5.95% |
| PRENTISS SMITH & CO INC | 136,441 | $10,133,000 | 5.74% |
| MANAGED ASSET PORTFOLIOS, LLC | 204,985 | $15,225,000 | 5.46% |
| Osher Van de Voorde Investment Management | 108,725 | $8,075,000 | 4.40% |
| BROWN BROTHERS HARRIMAN & CO | 10,796,684 | $801,870,000 | 4.35% |
| SECTORAL ASSET MANAGEMENT INC | 472,296 | $35,077,000 | 4.10% |
| PROFESSIONAL ADVISORY SERVICES INC | 235,347 | $17,479,000 | 3.87% |
| Elefante Mark B | 5,619 | $417,000 | 3.78% |
| SPHERA FUNDS MANAGEMENT LTD. | 255,000 | $18,959,000 | 3.71% |
| CGOV Asset Management | 997,161 | $98,662,000 | 3.61% |